Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Rhythm Pharmaceuticals Inc shares valued at $126,742 were sold by Smith Hunter C on Feb 19 ’25. At $57.22 per share, Smith Hunter C sold 2,215 shares. The insider’s holdings dropped to 109,929 shares worth approximately $5.68 million following the completion of this transaction.
Also, Shulman Joseph sold 1,228 shares, netting a total of over 70,266 in proceeds. Following the sale of shares at $57.22 each, the insider now holds 8,509 shares.
Before that, Meeker David P had sold 9,896 shares from its account. In a trade valued at $566,249, the President and CEO traded Rhythm Pharmaceuticals Inc shares for $57.22 each. Upon closing the transaction, the insider’s holdings decreased to 9,896 shares, worth approximately $10.39 million.
Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of December 20, 2024, Oppenheimer has initiated its “an Outperform” rating for RYTM. Earlier on October 21, 2024, Guggenheim initiated its rating. Their recommendation was “a Buy” for RYTM stock.
Analyzing RYTM Stock Performance
During the last five days, there has been a drop of approximately -2.57%. Over the course of the year, Rhythm Pharmaceuticals Inc shares have dropped approximately -7.75%. Shares of the company reached a 52-week high of $62.14 on 02/05/25 and a 52-week low of $50.12 on 03/04/25. A 50-day SMA is recorded $56.62, while a 200-day SMA reached $50.95.
Support And Resistance Levels for Rhythm Pharmaceuticals Inc (RYTM)
According to the 24-hour chart, there is a support level at 51.01, which, if violated, would cause prices to drop to 50.38. In the upper region, resistance lies at 52.76. The next price resistance is at 53.87. RSI (Relative Strength Index) is 37.46 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.90, which suggests the price will decrease in the coming days. Percent R is at 81.77%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Rhythm Pharmaceuticals Inc (RYTM)?
On September 18, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $64.
